BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27527868)

  • 21. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
    Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic value of abnormally expressed lncRNAs in colorectal cancer: A meta-analysis.
    Wang J; Du S; Wang J; Fan W; Wang P; Zhang Z; Xu P; Tang S; Deng Q; Yang W; Yu M
    PLoS One; 2017; 12(6):e0179670. PubMed ID: 28658310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Value of Long Noncoding RNAs in Patients with Gastrointestinal Cancer: A Systematic Review and Meta-Analysis.
    Kang W; Zheng Q; Lei J; Chen C; Yu C
    Dis Markers; 2018; 2018():5340894. PubMed ID: 30598708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA MRCCAT1 promotes metastasis of clear cell renal cell carcinoma via inhibiting NPR3 and activating p38-MAPK signaling.
    Li JK; Chen C; Liu JY; Shi JZ; Liu SP; Liu B; Wu DS; Fang ZY; Bao Y; Jiang MM; Yuan JH; Qu L; Wang LH
    Mol Cancer; 2017 Jun; 16(1):111. PubMed ID: 28659173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.
    Liu Z; Yan HY; Xia SY; Zhang C; Xiu YC
    Mol Med Rep; 2016 Apr; 13(4):3206-12. PubMed ID: 26934858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNAs as novel serum biomarkers for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis.
    Zheng C; Hao H; Chen L; Shao J
    Clin Transl Oncol; 2017 Aug; 19(8):961-968. PubMed ID: 28188488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A group of long noncoding RNAs identified by data mining can predict the prognosis of lung adenocarcinoma.
    Liao M; Liu Q; Li B; Liao W; Xie W; Zhang Y
    Cancer Sci; 2018 Dec; 109(12):4033-4044. PubMed ID: 30290038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
    Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
    PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diagnostic and prognostic significance of long noncoding RNAs expression in thyroid cancer: A systematic review and meta-analysis.
    Jing W; Li X; Peng R; Lv S; Zhang Y; Cao Z; Tu J; Ming L
    Pathol Res Pract; 2018 Mar; 214(3):327-334. PubMed ID: 29487006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA HOTTIP is upregulated in renal cell carcinoma and regulates cell growth and apoptosis by epigenetically silencing of LATS2.
    Peng F; Shi X; Meng Y; Dong B; Xu G; Hou T; Shi Y; Liu T
    Biomed Pharmacother; 2018 Sep; 105():1133-1140. PubMed ID: 30021349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic signatures for renal cancer as identified by long non-coding and miRNA competing endogenous network analysis.
    Gao H; Chen X; Shang Z; Niu Y
    Oncol Rep; 2018 Aug; 40(2):959-967. PubMed ID: 29901101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis.
    Gu L; Li H; Gao Y; Ma X; Chen L; Li X; Zhang Y; Fan Y; Zhang X
    PLoS One; 2015; 10(5):e0125538. PubMed ID: 25955026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
    Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
    Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression pattern of long non-coding RNAs in renal cell carcinoma revealed by microarray.
    Qin C; Han Z; Qian J; Bao M; Li P; Ju X; Zhang S; Zhang L; Li S; Cao Q; Lu Q; Li J; Shao P; Meng X; Zhang W; Yin C
    PLoS One; 2014; 9(6):e99372. PubMed ID: 24905231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA MALAT1 as a valuable biomarker for prognosis in osteosarcoma: A systematic review and meta-analysis.
    Liu M; Yang P; Mao G; Deng J; Peng G; Ning X; Yang H; Sun H
    Int J Surg; 2019 Dec; 72():206-213. PubMed ID: 31734255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.
    Jing W; Li N; Wang Y; Liu X; Liao S; Chai H; Tu J
    Oncotarget; 2017 Jan; 8(3):3957-3968. PubMed ID: 27992369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long non-coding RNAs and renal cell carcinoma.
    Fedorko M; Febu ; Bohušová J; Poprach A; Pacík D
    Klin Onkol; 2020; 33(5):340-349. PubMed ID: 33108878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H
    Oncotarget; 2017 Oct; 8(45):79061-79072. PubMed ID: 29108287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum long non-coding RNAs MALAT1, AFAP1-AS1 and AL359062 as diagnostic and prognostic biomarkers for nasopharyngeal carcinoma.
    He B; Zeng J; Chao W; Chen X; Huang Y; Deng K; Huang Z; Li J; Dai M; Chen S; Huang H; Dai S
    Oncotarget; 2017 Jun; 8(25):41166-41177. PubMed ID: 28467811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
    Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.